HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Refsum's disease: management by diet and plasmapheresis.

Abstract
A case of Refsum's disease treated by serial plasma exchanges together with a moderate low phytanate diet is reported. Serial plasma exchanges determined a rapid significant clinical improvement (neuropathy and cerebellar ataxia) that allowed immediate return to full-time employment. The initial improvement could be maintained by intermittent serial plasmapheresis despite partial failure of the initially introduced low phytanate diet bringing 20 mg phytanic acid daily. A new dietary regimen bringing 10 mg phytanic acid was later introduced that was well tolerated. No liquid formula was used. The clinical improvement was clearly correlated to a fall in serum phytanic acid from 45.3 to 16.2 mg/100 ml.
AuthorsJ P Hungerbühler, C Meier, L Rousselle, P Quadri, J Bogousslavsky
JournalEuropean neurology (Eur Neurol) Vol. 24 Issue 3 Pg. 153-9 ( 1985) ISSN: 0014-3022 [Print] Switzerland
PMID2581787 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Eicosanoic Acids
  • Phytanic Acid
Topics
  • Adult
  • Combined Modality Therapy
  • Eicosanoic Acids (administration & dosage)
  • Humans
  • Male
  • Phytanic Acid (administration & dosage, blood)
  • Plasmapheresis
  • Refsum Disease (blood, diet therapy, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: